At the news
? NEUTRALIMPACT 2/10 8-K filed Jul 23, 2026 at 07:00 ET
United Therapeutics appointed Victor Dzau, M.D., former President of the National Academy of Medicine, to its Board of Directors on July 22, 2026. This is a routine board refreshment appointment of a highly credentialed academic and healthcare leader, with no material financial impact or change in corporate strategy disclosed. The filing contains no financial data, guidance, or operational updates.
- Board size increased to 13 members with the appointment of Victor Dzau, M.D.
- Dr. Dzau recently completed a 12-year tenure as President of the National Academy of Medicine.
- Dr. Dzau received initial equity grants of 380 RSUs and 1,190 stock options, plus pro-rata grants of 350 RSUs and 1,110 stock options for the remainder of the 2026-2027 board service year.
- No material transactions between Dr. Dzau and the company exceeding $120,000.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access